参考文献/References:
[1] VERNON G,BARANOVA A,YOUNOSSI Z M.Systematic review:the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults[J].Aliment Pharmacol Ther,2011,34(3):274-285.
[2] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版)[J].实用肝脏病杂志,2018,21(2):177-186.
NATIONAL WORKSHOP ON FATTY LIVER AND ALCOHOLIC LIVER DISEASE,CHINESE SOCIETY OF HEPATOLOGY,CHINESE MEDICAL ASSOCIATION FATTY LIVER EXPERT COMMITTEE,CHINESE MEDICAL DOCTOR ASSOCIATION.Guidelines of prevention and treatment for nonalcoholic fatty liver disease:a 2018 update[J].J Prac Hepatol,2018,21(2):177-186.
[3] YOUNOSSI Z M,KOENIG A B,ABDELATIF D,et al.Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence,incidence,and outcomes[J].Hepatology,2016,64(1):73-84.
[4] LI J,ZOU B,YEO Y H,et al.Prevalence,incidence,and outcome of non-alcoholic fatty liver disease in Asia,1999-2019:a systematic review and meta-analysis[J].Lancet Gastroenterol Hepatol,2019,4(5):389-398.
[5] ZHOU F,ZHOU J,WANG W,et al.Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018:a systematic review and meta-analysis[J].Hepatology,2019,70(4):1119-1133.
[6] WANG F S,FAN J G,ZHANG Z,et al.The global burden of liver disease:the major impact of China[J].Hepatology,2014,60(6):2099-2108.
[7] LIU X,LI Y,GUO Y,et al.The burden,management rates and influencing factors of high blood pressure in a Chinese rural population:the rural diabetes,obesity and lifestyle (RuralDiab) study[J].J Hum Hypertens,2018,32(3):236-246.
[8] LIU X,MAO Z,LI Y,et al.Cohort profile:the henan rural cohort:a prospective study of chronic non-communicable diseases[J].Int J Epidemiol,2019,48(6):1756.
[9] 何美安,张策,朱江,等.东风-同济队列研究:研究方法及调查对象基线和第一次随访特征[J].中华流行病学杂志,2016,37(4):480-485.
HE M A,ZHANG C,ZHU J,et al.Dongfeng-Tongji cohort:methodology of the survey and the characteristics of baseline and initial population of follow-up program[J].Chin J Epidemiol,2016,37(4):480-485.
[10] 国务院人口普查办公室.中国2010人口普查资料[M/OL].北京:中国统计出版社,2011[2022-02-16].http://www.stats.gov.cn/tjsj/pcsj/rkpc/6rp/indexce.htm.
CENSUS OFFICE OF THE STATE COUNCIL.China 2010 Census Data[M/OL].Beijing:China Statistics Press,2011[2022-02-16].http://www.stats.gov.cn/tjsj/pcsj/rkpc/ 6rp/indexce.htm.
[11] ZHOU J,ZHOU F,WANG W,et al.Epidemiological features of NAFLD from 1999 to 2018 in China[J].Hepatology,2020,71(5):1851-1864.
[12] 王学玲,宋维芳,王丽君.吕梁地区常住居民非酒精性脂肪肝病与体质指数及腰臀比的调查研究[J].肝脏,2015,20(12):999-1002.
WANG X L,SONG W F,WANG L J.Nonalcoholic fatty liver disease,body mass index and waist-hip ratio among residents in Lvliang area[J].Chin Hepatol,2015,20(12):999-1002.
[13] WU R,HOU F,WANG X,et al.Nonalcoholic fatty liver disease and coronary artery calcification in a northern chinese population:a cross sectional study[J].Sci Rep,2017,7(1):9933.
[14] LI J,NI J,WU Y,et al.Sex differences in the prevalence,awareness,treatment,and control of diabetes mellitus among adults aged 45 years and older in rural areas of northern china:a cross-sectional,population-based study[J].Front Endocrinol (Lausanne),2019,10:147.
[15] KOZAKOWSKI J,GIETKA-CZERNEL M,LESZCZY N'SKA D,et al.Obesity in menopause-our negligence or an unfortunate inevitability[J].Prz Menopauzalny,2017,16(2):61-65.
[16] 中国肥胖问题工作组.中国成人超重和肥胖症预防与控制指南(节录)[J].营养学报,2004(1):1-4.
CHINA WORKING GROUP ON OBESITY.Guidelines for prevention and control of overweight and obesity among adults in China (excerpt)[J].Acta Nutrimenta Sinica,2004(1):1-4.
[17] OLIVEROS E,SOMERS V K,SOCHOR O,et al.The concept of normal weight obesity[J].Prog Cardiovasc Dis,2014,56(4):426-433.
[18] 王珊,张健,蒋晓忠,等.非肥胖人群的腰围轨迹与新发非酒精性脂肪肝的相关性[J].中华流行病学杂志,2020,41(6):824-828.
WANG S,ZHANG J,JIANG X Z,et al.Relationship between waist circumference trajectory and new-onset non alcoholic fatty liver disease in the non-obese population[J].Chin J Epidemiol,2020,41(6):824-828.
[19] 霍艳蓓,白亚娜,张德生,等.金昌队列人群非酒精性脂肪肝发病的影响因素分析[J].中华流行病学杂志,2021,42(3):493-498.
HUO Y B,BAI Y N,ZHANG D S,et al.Analysis on influencing factors for nonalcoholic fatty liver disease in Jinchang cohort[J].Chin J Epidemiol,2021,42(3):493-498.
[20] LI H,GUO M,AN Z,et al.Prevalence and risk factors of metabolic associated fatty liver disease in Xinxiang,China[J].Int J Environ Res Public Health,2020,17(6):1818.
[21] 刘肖肖,李书青,张倩,等.糖尿病合并肾功能不全患者HbA1c估算平均血糖校正模型的建立[J].解放军医学杂志,2022,47(5):458-463.
LIU X X,LI S Q,ZHANG Q,et al.Establishment of a correction model to estimate the mean blood glucose by HbA1c for diabetic patients with renal insufficiency[J].Med J Chin PLA,2022,47(5):458-463.
[22] 王鲁伃.非酒精性脂肪肝人群中HbA_(1c)诊断糖尿病的应用研究[J].中国社区医师,2017,33(35):115-116.
WANG L Y.Application of HbA1c in the diagnosis of diabetes mellitus in patients with nonalcoholic fatty liver disease[J].Chin Commun Doctors,2017,33(35):115-116.
[23] 吴婉雯,李晓伟,崔立红.脂肪肝诊断标准的变更对心血管疾病风险分层管理的价值分析[J].解放军医学杂志,2021,46(5):486-491.
WU W F,LI X W,CUI L H.The value of changes in diagnostic criteria for fatty liver in stratified management of cardiovascular risk[J].Med J Chin PLA,2021,46(5):486-491.
[24] 郭亮,任璐.慢性心力衰竭患者高密度脂蛋白胆固醇、高敏肌钙蛋白T水平与心功能的相关性[J].解放军预防医学杂志,2017,35(9):1091-1094.
GUO L,REN L.Relationships between high-density lipoprotein,high-sensitivity cardiac troponin T and cardiac function in patients with chronic heart failure[J].Med J Chin PLA,2017,35(9):1091-1094.
[25] 吴祖飞,陈诗,刘叶红,等.血清CRP/白蛋白、HCY/HDL-C与冠状动脉病变程度的相关性分析[J].解放军医学杂志,2021,46(7):678-686.
WU Z F,CHEN S,LIU Y H,et al.Relationship between CRP/albumin,HCY/HDL-C and the severity of coronary artery disease[J].Med J Chin PLA,2021,46(7):678-686.
[26] SANCHES P L,DE PIANO A,CAMPOS R M,et al.Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents:the role of interdisciplinary therapy[J].J Clin Lipidol,2014,8(3):265-272.
[27] SCHWIMMER J B,PARDEE P E,LAVINE J E,et al.Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease[J].Circulation,2008,118(3):277-283.
[28] SPAHIS S,DELVIN E,BORYS J M,et al.Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis[J].Antioxid Redox Signal,2017,26(10):519-541.
[29] SEO Y B,HAN A L.Association of the serum uric acid-to-creatinine ratio with nonalcoholic fatty liver disease diagnosed by computed tomography[J].Metab Syndr Relat Disord,2021,19(2):70-75.
[30] 邵翠萍,徐有青.血清尿酸/肌酐比值与非酒精性脂肪性肝病的相关性分析[J].临床肝胆病杂志,2021,37(10):2348-2351.
SHAO C P,XU Y Q.Association of serum uric acid-to-creatinine ration with nonalcoholic fatty liver disease[J].J Clin Hepatol,2021,37(10):2348-2351.